Lp(a) and premature mortality during chronic hemodialysis treatment
- 31 January 1994
- journal article
- Published by Elsevier in Chemistry and Physics of Lipids
- Vol. 67-68, 419-427
- https://doi.org/10.1016/0009-3084(94)90165-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.Circulation, 1992
- Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients.Circulation, 1988
- Measurement of total HDL, HDL2 and HDL3 by dextran sulfate—MgCl2 precipitation technique in human serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- The Association of Serum Lipids, Lipoproteins, and Apolipoproteins with Coronary Artery Disease Assessed by Coronary ArteriographyAnnals of the New York Academy of Sciences, 1985
- Abnormal cell-interactive properties of low-density lipoproteins isolated from patients with chronic renal failureMetabolism, 1985
- Putative atherogenic factors in patients with chronic renal failureProgress in Cardiovascular Diseases, 1983
- Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemiasAtherosclerosis, 1983
- Racial Differences in Plasma High-Density Lipoproteins in Patients Receiving HemodialysisNew England Journal of Medicine, 1983
- Increased Lipoprotein-Remnant Formation in Chronic Renal FailureNew England Journal of Medicine, 1982
- Accelerated Atherosclerosis in Prolonged Maintenance HemodialysisNew England Journal of Medicine, 1974